BMS Dives Deeper Into China With First Discovery Partnership
This article was originally published in The Pink Sheet Daily
Executive Summary
BMS doubling down in China with discovery deal with Beijing’s Tsinghua University and plans to ramp up in diabetes and hepatitis.
You may also be interested in...
Insider Analysis From Easton Associates: Are Patient Assistance Programs The Silver Bullet To Meet Affordability Challenges In China?
By Celia Deng, Zhiyi Tong and Paul Zhang
Fresh Off BMS Deal, Leading Chinese CRO WuXi PharmaTech Outlines Plan To Expand Biologics Business To Keep Pace With Big Pharma
BEIJING - Betting on the belief that Big Pharma will speed up the transfer of research and manufacturing to China, leading contract research organization WuXi PharmaTech is expanding its chemistry services even while preparing to launch a new biologics testing and production center near its headquarters in Shanghai
Spectacular Market Launches Key To Enduring Success Of Brands In APAC - IMS Health
MUMBAI - Following studies on the launch of patented brands in the Asia-Pacific market, IMS Health said less than 20 percent of brands perform well if they do not strike significant success within the first six months of their launches